Skip to main content
Premium Trial:

Request an Annual Quote

New Zealand Medical Lab Adopts Roche NimbleGen Arrays to Study Mental Retardation


By Justin Petrone

One of the largest medical laboratories in New Zealand has adopted Roche NimbleGen's microarray platform, Roche said this week.

Canterbury Health Laboratories will use Roche NimbleGen's CGX cytogenetics arrays for its research on developmental delay and mental retardation. As part of the platform adoption, Christchurch-based Canterbury has implemented the NimbleGen workflow for cytogenetics, including arrays, reagents, instruments, and software, in its core facility, Roche said.

The laboratory will initially use NimbleGen CGX-12 arrays for its research. The whole-genome oligonucleotide arrays enable users to survey more than 200 cytogenetically relevant regions, including more than 675 functionally significant genes. Roche began selling the chips that are based on a design by Signature Genomics, now part of PerkinElmer, last year (BAN 11/10/2009).

Canterbury claims to be the largest medical testing lab on New Zealand's South Island. In addition to its Christchurch headquarters, Canterbury maintains smaller laboratories and collection centers at Ashburton, Burwood, and Princess Margaret Hospital in Christchurch.

Roche said the lab, which specializes in medical and genetic research, including neonatal cytogenetic testing, also services other Asia Pacific regions including Australia.

Financial details of Roche's deal with Canterbury were not discussed.

Have topics you'd like to see covered in BioArray News? Contact the editor at jpetrone [at] genomeweb [.] com.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.